Latest Stock Market News

​New sales bookings rose 158% YoY to INR27b (v/s our estimate ofINR23.5b) in 4QFY22, led by sustained momentum in the ultra-luxury Camellias project and strong response to its new product launches, including independent floors and luxury project – ‘One Midtown’.

​Revenue rose 17% YoY to INR14b (est. INR13.3b) in 4QFY22. Exports (CSM business) grew 11% YoY to INR11.1 b and the domestic business grew 47% YoY to INR2.8b in 4QFY22.

Rate this item

(1 Vote)

A total of 1,872,867 shares changed hands on the counter till 01:23PM (IST)

Rate this item

(1 Vote)

Overseas investors disposed a combined net total of $2.35 billion in South Korea, Thai, Indian, Indonesian and Malaysian bonds last month, data from regulatory authorities and bond market associations showed. It was the second consecutive monthly selling by foreigners in Asian bonds, according to the data.

Tokyo shares close higher extending US gains

Updated at : 2022-05-18 14:20:01

Rate this item

(1 Vote)

The benchmark Nikkei 225 index gained 0.94 percent, or 251.45 points, to end at 26,911.20, while the broader Topix index climbed 0.96 percent, or 17.98 points, to 1,884.69

Rate this item

(1 Vote)

As D-Street seems to be caught in a perfect storm, uncertainty and volatility will likely prevail in the near term, spelling tougher times for new investors facing a correction of such magnitude for the first time. Market experts suggest that this kind of volatility was expected and one should stay invested in the market.

Rate this item

(1 Vote)

Promoters held 58.69 per cent stake in the company as of 31-Mar-2022, while FIIs owned 1.15 per cent, DIIs 18.28 per cent.

Rate this item

(1 Vote)

Century Plyboards (India), incorporated in the year 1982, is a Mid Cap company (having a market cap of Rs 11892.92 crore) operating in Building Materials sector.

Rate this item

(1 Vote)

As of March 31, Patanjai Ayurved held a 39.37 per cent stake in Ruchi Soya. Acharya Balkrishna, one of the promoters and chairman of Ruchi Soya, holds 98.5 per cent of the paid up equity share capital of Patanjali Ayurved.

Rate this item

(1 Vote)

Dr Lal faces a tough FY23 as Covid ebbs away from revenues even as base quarters had a significant proportion of Covid sales.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.